论文部分内容阅读
目的:观察喜炎平注射液雾化吸入联合抗菌药物治疗肺部感染老年患者的临床疗效。方法:选取98例肺部感染老年患者作为研究对象,按随机数字表法均分为对照组和观察组各49例,2组均以常规治疗,对照组雾化吸入庆大霉素及地塞米松,观察组在对照组治疗基础上加雾化吸入喜炎平注射液,治疗10天后对2组患者的临床效果进行分析比较。结果:观察组总有效率为95.92%,对照组总有效率为79.59%,2组比较,差异有统计学意义(P<0.01)。观察组退热时间、咳嗽缓解时间及肺部啰音消失时间均短于对照组,差异均有统计学意义(P<0.05)。观察组不良反应发生率为2.04%,对照组不良反应发生率为10.20%,2组比较,差异有统计学意义(P<0.05)。结论:在常规治疗基础上以雾化吸入喜炎平注射液联合抗菌药物治疗肺部感染老年患者的临床效果显著,且安全性好,值得临床推广。
Objective: To observe the clinical efficacy of Xiyanping injection combined with antimicrobial agents in the treatment of elderly patients with pulmonary infection. Methods: Ninety-nine elderly patients with pulmonary infection were selected as study subjects, and randomly divided into control group and observation group according to random number table method, 49 cases in each group. Both groups were treated by routine therapy. In the control group, gentamicin and gemcitabine In the control group, the rats in the control group received inhalation of Xiyanping injection. The clinical effects of the two groups were analyzed and compared after 10 days of treatment. Results: The total effective rate was 95.92% in the observation group and 79.59% in the control group. There was significant difference between the two groups (P <0.01). The observation group antipyretic time, cough relief time and pulmonary rales disappeared time were shorter than the control group, the difference was statistically significant (P <0.05). The incidence of adverse reactions in the observation group was 2.04%, and the incidence of adverse reactions in the control group was 10.20%. There was significant difference between the two groups (P <0.05). Conclusion: Based on the conventional treatment, inhalation of Xiyanping injection combined with antimicrobial drugs in the treatment of elderly patients with lung infection has a significant clinical effect, and safety is good, worthy of clinical promotion.